Drug Profile
BiAmine
Latest Information Update: 09 Feb 2001
Price :
$50
*
At a glance
- Originator Serotonin Pharmaceuticals
- Class Anorectics
- Mechanism of Action Neurotransmitter stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cocaine-related disorders; Obesity
Most Recent Events
- 09 Feb 2001 No-Development-Reported for Cocaine abuse in USA (Unknown route)
- 09 Feb 2001 No-Development-Reported for Obesity in USA (Unknown route)
- 11 Nov 1996 Preclinical development for Obesity in USA (Unknown route)